Table 1. Correlation between clinicopathological features and CD8+ TILs.
Characteristics | N | Organ-confined | P | Characteristics | N | Non-organ-confined | P | ||
---|---|---|---|---|---|---|---|---|---|
CD8+ | CD8− | Fisher exact test | CD8+ | CD8− | Fisher exact test | ||||
Age (years) | 0.296 | 0.760 | |||||||
<60 | 36 | 24 | 12 | 18 | 13 | 5 | |||
≥60 | 39 | 31 | 8 | 33 | 22 | 11 | |||
Sex | 1.000 | 0.295 | |||||||
Male | 64 | 47 | 17 | 47 | 31 | 16 | |||
Female | 11 | 8 | 3 | 4 | 4 | 0 | |||
pT stage | 0.033 | pT stage | 0.345 | ||||||
pTa-1 | 31 | 27 | 4 | pT3 | 34 | 25 | 9 | ||
pT2 | 44 | 28 | 16 | pT4 | 17 | 10 | 7 | ||
pN stage | pN stage | 0.746 | |||||||
N− | 35 | 23 | 12 | ||||||
N+ | 16 | 12 | 4 | ||||||
Nuclear grade | 0.107 | ||||||||
Low | 26 | 16 | 10 | ||||||
High | 49 | 39 | 10 | ||||||
Adjuvant chemotherapy, n (%) | 0.114 | 0.527 | |||||||
Not Administered | 70 | 53 | 17 | 34 | 22 | 12 | |||
Administered | 5 | 2 | 3 | 17 | 13 | 4 | |||
Neo-adjuvant chemotherapy, n (%) | 1.000 | 0.643 | |||||||
Not Administered | 65 | 48 | 17 | 5 | 3 | 2 | |||
Administered | 10 | 7 | 3 | 46 | 32 | 14 |